Antibiotic Prophylaxis Is Associated with Subsequent Resistant Infections in Children with an Initial Extended-Spectrum-Cephalosporin-Resistant Enterobacteriaceae Infection

Abstract

The objective of this study was to assess the association between previous antibiotic use, particularly long-term prophylaxis, and the occurrence of subsequent resistant infections in children with index infections due to extended-spectrumcephalosporin-resistant Enterobacteriaceae. We also investigated the concordance of the index and subsequent isolates. Extended-spectrum-cephalosporin-resistant Escherichia coli and Klebsiella spp. isolated from normally sterile sites of patients aged Ͻ22 years were collected along with associated clinical data from four freestanding pediatric centers. Subsequent isolates were categorized as concordant if the species, resistance determinants, and fumC-fimH (E. coli) or tonB (Klebsiella pneumoniae) type were identical to those of the index isolate. In total, 323 patients had 396 resistant isolates; 45 (14%) patients had Ն1 subsequent resistant infection, totaling 73 subsequent resistant isolates. The median time between the index and first subsequent infections was 123 (interquartile range, 43 to 225) days. In multivariable Cox proportional hazards analyses, patients were 2.07 times as likely to have a subsequent resistant infection (95% confidence interval, 1.11 to 3.87) if they received prophylaxis in the 30 days prior to the index infection. In 26 (58%) patients, all subsequent isolates were concordant with their index isolate, and 7 (16%) additional patients had at least 1 concordant subsequent isolate. In 12 of 17 (71%) patients with E. coli sequence type 131 (ST131)-associated type 40-30, all subsequent isolates were concordant. Subsequent extended-spectrum-cephalosporin-resistant infections are relatively frequent and are most commonly due to bacterial strains concordant with the index isolate. Further study is needed to assess the role prophylaxis plays in these resistant infections.

<p>Multi-Drug Resistant <em>Escherichia coli</em> Causing Early-Onset Neonatal Sepsis – a Single Center Experience from China</p>

“…Clearly, causes other than NICU practice were responsible for the fact that ESBL-producing E. coli has emerged as the main pathogen for EOS in our NICU. There are several studies that have demonstrated the relationship between the antibiotic chosen for IAP and resistant E. coli infections in neonates 21,22. Colonization of resistant bacteria in pregnant women during hospitalization may be another reason.…”

Microbiological characteristics of early and late infectious complications following total pelvic exenteration due to cervical cancer recurrence—the significance of infections in long-term outcomes

“…Koh et al [27] suggest that prolonged courses of antibiotic administration in PE may reduce septic complications, which is in contrast to the findings of Ishibashi et al [28] on patients undergoing surgery for rectal cancer; the authors did not observe a significant reduction in SSI incidence among patients receiving a single dose of postoperative antibiotics vs. multiple-dose antibiotics. Other authors argue that prolonged courses of antibiotic prophylaxis may cause the risk of increasing microbial resistance infections [29,30]. However, in a large retrospective cohort study by Cohen et al [31], among 689 patients with post-operative infections, there was no association between antibiotic prophylaxis and post-operative antibiotic-resistant infections.…”

Epidemiology and Antimicrobial Resistance Characteristics of the Sequence Type 131-H30 Subclone Among Extraintestinal Escherichia coli Collected From US Children

“…For each resistant isolate, 3 consecutive E. coli isolates that were susceptible to the aforementioned agents, referred to here as extended-spectrum cephalosporin-susceptible (ESC-S) isolates, were collected without respect to any patient or microbiological characteristics beyond temporal proximity to the ESC-R isolates and prior enrollment in the study (patients could only contribute 1 ESC-S isolate). Demographic and clinical data were collected from the medical records; methods for categorizing underlying medical conditions, capturing antibiotic exposure, and characterizing the clinical significance of urine isolates (likely urinary tract infection vs not) were described previously [21,22]. The institutional review board at each hospital approved the study protocol.…”